Literature DB >> 448525

Additional evidence against measles vaccine administration to infants less than 12 months of age: altered immune response following active/passive immunization.

J Wilkins, P F Wehrle.   

Abstract

Quantitative serologic responses following the inoculation of infants less than one year of age with live, further-attenuated measles virus vaccine were compared to those of infants and children inoculated after one year of age. Active/passive immunization resulted in reduced antibody formation in some infants especially those less than 9 months of age. Thirty-seven infants identified as "vaccine failures" following their initial inoculation at less than one year of age were revaccinated after one year of age. Fifty-one percent had no detectable HI antibody by eight months postrevaccination, contrasted to 6.8% of the vaccinees with no detectable HI antibody following one inoculation after one year of age; 49% responded optimally to revaccination. In face of an observed altered response in many infants less than one year of age, it would appear prudent to withhold vaccine in this age group until the consequences of such an approach are better defined.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 448525     DOI: 10.1016/s0022-3476(79)80203-6

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  14 in total

1.  Are your patients protected from rubeola?

Authors:  W Feldman
Journal:  Can Fam Physician       Date:  1981-03       Impact factor: 3.275

2.  Increasing the time of exposure to aerosol measles vaccine elicits an immune response equivalent to that seen in 9-month-old Mexican children given the same dose subcutaneously.

Authors:  Rosa María Wong-Chew; Miguel Leonardo García-León; Bogart Espinosa-Torres Torrija; Brenda Hernández-Pérez; Lino E Cardiel-Marmolejo; Judy A Beeler; Susette Audet; José Ignacio Santos-Preciado
Journal:  J Infect Dis       Date:  2011-08-01       Impact factor: 5.226

3.  Decay of passively acquired maternal antibodies against measles, mumps, and rubella viruses.

Authors:  C Nicoara; K Zäch; D Trachsel; D Germann; L Matter
Journal:  Clin Diagn Lab Immunol       Date:  1999-11

Review 4.  Two-dose measles vaccination schedules.

Authors:  S R Rosenthal; C J Clements
Journal:  Bull World Health Organ       Date:  1993       Impact factor: 9.408

5.  Inadequate immunity to measles in children vaccinated at an early age: effect of revaccination.

Authors:  F L Black; L L Berman; M Libel; C A Reichelt; F D Pinheiro; A Travassos da Rosa; F Figueira; E Siqueira Gonzales
Journal:  Bull World Health Organ       Date:  1984       Impact factor: 9.408

6.  Viral vaccines: the use of currently available products and future developments.

Authors:  E Norrby
Journal:  Arch Virol       Date:  1983       Impact factor: 2.574

7.  Appropriate strategy for immunization of children in India. IV: Measles and its control, priority number one.

Authors:  M C Steinhoff; T J John
Journal:  Indian J Pediatr       Date:  1982 May-Jun       Impact factor: 1.967

8.  Immune response to second dose of MMR vaccine in Indian children.

Authors:  Sunil Gomber; Shilpa Khanna Arora; Shukla Das; V G Ramachandran
Journal:  Indian J Med Res       Date:  2011-09       Impact factor: 2.375

9.  Time to re-think measles vaccination schedule in India.

Authors:  T Jacob John; Valsan P Verghese
Journal:  Indian J Med Res       Date:  2011-09       Impact factor: 2.375

10.  Outbreak of measles in Central and Eastern Cheshire, UK, October 2008-February 2009.

Authors:  S Ghebrehewet; G Hayhurst; A Keenan; H Moore
Journal:  Epidemiol Infect       Date:  2012-11-09       Impact factor: 4.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.